Treatment for Cerebral Autoregulation Mapping

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Health Sciences Centre (HSC), Winnipeg, Canada
Cerebral Autoregulation Mapping
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The investigators propose to employ advanced multi-channel near non-invasive near infrared spectroscopy (NIRS) system married with entirely non-invasive continuous arterial blood pressure (niABP) monitor to create a new wearable and portable imaging system that derives CA maps of the entire brain with high sampling rates at each point. The objectives of this project are as follows: To perform in vivo testing and optimization of the device using a block-trial design to evaluate the CA mapping system's performance during various perturbations. To explore the impact of aging and sex on regional disparities in CA in a healthy volunteer population using static recording along with perturbation testing.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Cerebral Autoregulation Mapping

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 3 years

2 years
In Vivo testing and optimization of device during various perturbations
3 years
Explore impact of aging and sex on regional disparities in Cerebral Autoregulation

Trial Safety

Safety Progress

1 of 3

Other trials for Cerebral Autoregulation Mapping

Trial Design

0 Treatment Group

250 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 years
Closest Location: Health Sciences Centre (HSC) · Winnipeg, Canada
Photo of manitoba 1Photo of manitoba 2Photo of manitoba 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Cerebral Autoregulation Mapping
0 CompletedClinical Trials

Who is running the clinical trial?

Natural Sciences and Engineering Research Council, CanadaOTHER
46 Previous Clinical Trials
2,174 Total Patients Enrolled
Health Sciences Centre, Winnipeg, ManitobaOTHER
14 Previous Clinical Trials
8,465 Total Patients Enrolled
University of ManitobaLead Sponsor
533 Previous Clinical Trials
185,861 Total Patients Enrolled
Frederick A Zeiler, MD PhD FRCSCPrincipal InvestigatorUniversity of Manitoba

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.